Quick Takeaways
- Jeffrey W. Henderson has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $6,487,537.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Jeffrey W. Henderson
- Location
- San Diego, CA
- Summary
- The estimated net worth of Jeffrey W. Henderson is at least $6,487,537 dollars as of 18 Mar 2026. Jeffrey W. Henderson is the Director of QUALCOMM INC/DE and owns shares of QUALCOMM INC/DE (QCOM) stock worth about $2.71M. Jeffrey W. Henderson is the Director of HALOZYME THERAPEUTICS, INC. and owns shares of HALOZYME THERAPEUTICS, INC. (HALO) stock worth about $1.97M. Jeffrey W. Henderson is the Director of BECTON DICKINSON & CO and owns shares of BECTON DICKINSON & CO (BDX) stock worth about $1.78M. Jeffrey W. Henderson is the Director of FIBROGEN INC and owns shares of KYNTRA BIO, INC. (KYNB) stock worth about $21.9K.
- Signature
- By: Jon Russo, Attorney-in-Fact For: Jeffrey W. Henderson
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Jeffrey W. Henderson and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: QUALCOMM INC/DE ($2,714,536).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Jeffrey W. Henderson
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| QCOM | QUALCOMM INC/DE | Director | $2,714,536 | 17 Mar 2026 | ||
| HALO | HALOZYME THERAPEUTICS, INC. | Director | $1,973,770 | -$271,467 | -12% | 01 May 2025 |
| BDX | BECTON DICKINSON & CO | Director | $1,777,293 | 27 Jan 2026 | ||
| KYNB | FIBROGEN INC | Director | $21,938 | 01 Sep 2023 |
Insider Transactions Reported by Jeffrey W. Henderson:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.